Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

ATP5L2 Inhibitors

ATP5L2 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of the ATP5L2 protein, a lesser-known but functionally relevant subunit related to the mitochondrial ATP synthase complex. ATP5L2 is thought to play a role similar to that of ATP5L, contributing to the stability and function of the ATP synthase enzyme, which is essential for the production of ATP via oxidative phosphorylation within the inner mitochondrial membrane. By inhibiting ATP5L2, these compounds can interfere with the assembly or functional stability of the ATP synthase complex, leading to disruptions in ATP production. This reduction in ATP synthesis has a direct effect on cellular energy homeostasis, making ATP5L2 inhibitors valuable tools for studying the specifics of mitochondrial energy metabolism and protein complex assembly.

The use of ATP5L2 inhibitors provides researchers with a means to explore the detailed mechanics of mitochondrial ATP production and how various subunits contribute to the overall function of ATP synthase. Inhibiting ATP5L2 offers insight into how modifications or disruptions in subunit function can affect not only energy production but also other downstream cellular processes dependent on ATP. These inhibitors allow for the investigation of how the subunit interacts with other components of the mitochondrial machinery, shedding light on the structural and functional dynamics of ATP synthase. Additionally, ATP5L2 inhibitors serve as critical tools for studying mitochondrial biogenesis, energy flux, and the regulation of metabolic processes at the cellular level, expanding the understanding of how mitochondria contribute to the complex network of cellular energy management.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Oligomycin A

579-13-5sc-201551
sc-201551A
sc-201551B
sc-201551C
sc-201551D
5 mg
25 mg
100 mg
500 mg
1 g
$175.00
$600.00
$1179.00
$5100.00
$9180.00
26
(1)

Oligomycin A binds to the OSCP subunit of ATP synthase, potentially affecting the stability and expression of associated subunits.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA, inhibiting transcription and potentially decreasing ATP5L2 mRNA levels.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide inhibits eukaryotic ribosomes, reducing protein translation and potentially lowering ATP5L2 protein levels.

Tetracycline

60-54-8sc-205858
sc-205858A
sc-205858B
sc-205858C
sc-205858D
10 g
25 g
100 g
500 g
1 kg
$62.00
$92.00
$265.00
$409.00
$622.00
6
(1)

Tetracycline binds to the 30S ribosomal subunit, possibly preventing ATP5L2 mRNA translation.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$163.00
$316.00
436
(1)

Puromycin causes premature chain termination during translation, which could reduce the synthesis of ATP5L2.

Chloramphenicol

56-75-7sc-3594
25 g
$53.00
10
(1)

Chloramphenicol inhibits bacterial ribosomes, which share similarities with mitochondrial ribosomes, potentially decreasing ATP5L2 synthesis.

Doxycycline-d6

564-25-0 unlabeledsc-218274
1 mg
$16500.00
(0)

Doxycycline, by inhibiting the 30S ribosomal subunit, could suppress mitochondrial protein translation including ATP5L2.

Emetine

483-18-1sc-470668
sc-470668A
sc-470668B
sc-470668C
1 mg
10 mg
50 mg
100 mg
$352.00
$566.00
$1331.00
$2453.00
(0)

Emetine inhibits eukaryotic ribosomal movement along mRNA, potentially curtailing ATP5L2 protein production.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin inhibits RNA polymerase in prokaryotes, and might affect mitochondrial transcription, reducing ATP5L2 expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin inhibits RNA polymerase II in eukaryotes, which could lead to decreased transcription of nuclear-encoded ATP5L2.